Exelixis Inc. buy Royal Bank of Canada
Start price
13.03.25
/
50%
€33.75
Target price
13.03.26
€36.74
Performance (%)
9.87%
End price
14.03.26
€37.08
Summary
This prediction ended on 14.03.26 with a price of €37.08. With a performance of 9.87%, the BUY prediction by Royal_Bank_of_Canada for Exelixis Inc. closed with a slight gain. Royal_Bank_of_Canada has a follow-up prediction for Exelixis Inc. where he still thinks Exelixis Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 1.033% | 1.033% | 19.855% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its price target raised by analysts at Royal Bank of Canada from $38.00 to $40.00. They now have an "outperform" rating on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

